Abstract
Lung cancer continues to represent a major public health concern with high morbidity and mortality worldwide. Early detection of lung cancer is problematic due to a lack of diagnostic markers with high sensitivity and specificity. To determine the differently expressed proteins in the serum of lung cancer and identify the function of such proteins, two-dimensional electrophoresis (2DE) and liquid chromatography mass spectrometry (LC-MS) were used to screen the serum of lung cancer model induced by 4-(methylnitrosoamino)-1-(3-pyridyl)-1-butanone (NNK). A total of 25 protein spots were qualitatively different and 6 were quantitatively different in the serum from rats bearing induced lung cancer when compared with normal controls. Two of the proteins that showed major changes in concentration in sera were identified to be Immunoglobulin γ 2A chain C region (heavy chain) and Transferrin by LC-MS/MS.
Similar content being viewed by others
References
Commonly Diagnosed Cancers Worldwide, Cancer Research UK, 2005
Jemal A., Tiwari R.C., Murray T., Ward E., Samuels A., Ghafoor A., et al., Cancer statistics, CA Cancer J. Clin., 2005, 54, 8–29
Li M., Ye B., Zhang Y., Chen H., Xia D., Liu M., et al., Proteomic analysis of serum in lung cancer induced by 3-methylcholanthrene, J. Biomed. Biotechnol., 2009, 1–12
Pandey A., Mann M., Proteomics to study genes and genomes, Nature, 2000, 405, 837–846
Alessandro R., Fontana S., Kohn E., De Leo G., Proteomic strategies and their application in cancer research, Tumori., 2005, 91, 447–455
Koomen J.M., Haura E.B., Bepler G., Sutphen R., Remily-Wood E.R., Benson K., et al., Proteomic contributions to personalized cancer care, Mol. Cell. Proteomics, 2008, 7, 1780–1794
Peng X.Q., Wang F., Geng X., Current advances in tumor proteomics and candidate biomarkers for hepatic cancer, Expert Rev. Proteomics, 2009, 6, 551–561
Simpson R.J., Bernhard O.K., Greening D.W., Moritz R.L., Proteomics-driven cancer biomarker discovery: looking to the future, Curr. Opin. Chem. Biol., 2008, 12, 72–77
Cho H.J., Baek K.E., Park S.M., Kim K.I., Choi Y.L., Cho H.J., et al., RhoGDI2 expression is associated with tumor growth and malignant progression of gastric cancer, Clin. Cancer Res., 2009, 15, 2612–2619
Hongsachart P., Huang-Liu R., Sinchaikul S., Pan F.M., Phutrakul S., Chuang Y.M., et al., Glycoproteomic analysis of WGA-bound glycoprotein biomarkers in sera from patients with lung adenocarcinoma, Electrophoresis, 2009, 30, 1206–1220
Ono M., Matsubara J., Honda K., Sakuma T., Hashiguchi T., Nose H., et al., Prolyl 4-hydroxylation of alpha-fibrinogen: A novel protein modification revealed by plasma proteomic, J. Biol. Chem., 2009, 284, 29041–29049
Schulz D.M., Böllner C., Thomas G., Atkinson M., Esposito I., Hofler H., et al., Identification of differentially expressed proteins in triplenegative breast carcinomas using DIGE and mass spectrometry, J. Proteome Res., 2009, 8, 3430–3438
Vellaichamy A., Sreekumar A., Strahler J.R., Rajendiran T., Yu J., Varambally S., et al., Proteomic interrogation of androgen action in prostate cancer cells reveals roles of aminoacyl tRNA synthetases, PLoS One, 2009, 4, e7075
Mathivanan S., Lim J.W., Tauro B.J., Ji H., Moritz R.L., Simpson R.J., Proteomic analysis of A33-immunoaffinity-purified exosomes released from the human colon tumor cell line LIM1215 reveals a tissue-specific protein signature, Mol. Cell. Proteomics, 2010 9, 197–208
Sagynaliev E., Steinert R., Nestler G., Lippert H., Knoch M., Reymond M.A., Web-based datawarehouse on gene expression in human colorectal cancer, Proteomics, 2005, 5, 3066–3078
Sung H.J., Cho J.Y., Biomarkers for the lung cancer diagnosis and their advances in proteomics, BMB reports, 2008, 41, 615–625
Zhang Y., Li M., Liu Y., Han N., Zhang K., Xiao T., et al., ENO1 protein levels in the tumor tissues and circulating plasma samples of non-small cell lung cancer patients, Chinese Journal of lung cancer, 2010, 13, 1089–1093
Ugurel S., Bell N., Sucker A., Zimpfer A., Rittgen, W., Schadendorf D., Tumor type M2 pyruvate kinase (TuM2-PK) as a novel plasma tumor marker in melanoma, Int. J. Cancer, 2005, 117,5, 825–830
Belinsky A., White M., Boucheron A., Richardson C., Swenberg A., Anderson M., Accumulation and persistence of DNA adducts in respiratory tissue of rats following multiple administrations of the tobacco specific carcinogen 4-(N-Methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone, Cancer Res., 1986, 46, 1280–1284
Tuck M.K., Chan D.W., Chia D., Godwin A.K., Grizzle W.E., Krueger K.E., et al., Standard operating procedures for serum and plasma collection: early detection research network consensus statement Standard Operating Procedure Integration Working Group, J. Proteome Res., 2009, 8, 113–117
Anderson N.L., Anderson N.G., The human plasma proteome: history, character, and diagnosis prospects, Mol. Cell. Proteomics, 2002, 1, 845–67
Laemmli U.K., Cleavage of structural proteins during the assembly of the head of bacteriophage T4, Nature, 1970, 227, 680–685
Bradford M.M., Rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding, Anal. Biochem., 1976, 72, 248–254
Huebers H.A., Finch C.A., The physiology of transferrin and transferrin receptors, Physiol. Rev., 1987, 67, 520–582
Kuvibidila S., Gauthier T., Warrier R.P., Rayford W., Increased levels of serum transferrin receptor and serum transferrin receptor/log ferritin ratios in men with prostate cancer and the implications for body-iron stores, J. Lab. Clin. Med., 2004, 144, 176–182
Faulk W.E., His B.L., Stevens P.J., Transferrin and transferrin receptors in carcinoma of the breast, Lancet, 1980, 2, 390–392
Lamoureux G., Mandeville R., Poisson R., Poisson S.L., Jolicoeur R., Biological markers and breast cancer. A multiparametric study, increased serum protein levels, Cancer, 1982, 49, 502–512
Stevens G., Graubard I., Micozzi S., Neriishi K., Blumberg B.S., Moderate elevation of body iron level and increase risk of cancer occurrence and death, Int. J. Cancer, 1994, 56, 364–369
Kassie F., Anderson L.B., Scerber R., Yu N., Lahti D., Upadhyaya P., Indole-3-carbinol Inhibits 4-(Methylnitrosamino)-1-(3-pyridyl)-1-butanone Plus Benzo(a)pyrene-Induced Lung Tumorigenesis in A/J Mice and Modulates Carcinogen-Induced Alterations in Protein Levels, Cancer Res., 2007, 67, 6502–6511
Knekt P.M., Reunanen A., Takkunen H., Body iron stores and risk of cancer, Int. J. Cancer, 1994, 56, 379–82
Eberini I., Miller I., Zancan V., Bolego C., Puglisi L., Gemeiner M., et al., Proteins of rat serum IV. Timecourse of acute-phase protein expression and its modulation by indomethacine, Electrophoresis, 1999, 20, 846–853
Eberini I., Agnello D., Miller I., Villa P., Fratelli M., Ghezzi P., et al., Proteins of rat serum V: adjuvant arthritis and its modulation by nonsteroidal antiinflammatory drugs, Electrophoresis, 2000, 21, 2170–2179
Haynes P., Miller I., Aebersold R., Gemeiner M., Eberini I., Lovati M.R., et al., Proteins of rat serum: I establishing a reference two-dimensional electrophoresis map by immunodetection and microbore high performance liquid chromatography electrospray mass spectrometry, Electrophoresis, 1998, 19, 1484–1492
Kimoto Y., Expression of heavy-chain constant region of immunoglobulin and T-cell receptor gene transcripts in human non-hematopoietic tumor cell lines, Genes Chromosomes Cancer, 1998, 22, 83–86
Qiu X., Zhu X., Zhang L., Mao Y., Zhang J., Hao P., et al., Human epithelial cancers secrete immunoglobulin G with unidentified specificity to promote growth and survival of tumor cells, Cancer Research, 2003, 63, 6488–6495
Olubuyide I.O., Salimonu L.S., Adeniran S.O., Soluble immune complexes and immunoglobulin (IgG, IgA and IgM) levels in Nigerians with primary liver cell carcinoma, Afr. J. Med. Sci., 1993, 22, 57–62
Ouyang G., Chen Y., Ruan L., Differential phosphoproteome analysis of nasopharyngeal carcinoma and normal nasopharyngeal epithelial tissues, Int. J. Path. Clin. Med., 2007, 27, 461–469
Author information
Authors and Affiliations
Corresponding author
About this article
Cite this article
Bhatnagar, S., Chaudhary, N., Malik, S. et al. Proteomic analysis of differentially expressed serum proteins in lung cancer. cent.eur.j.biol. 7, 343–353 (2012). https://doi.org/10.2478/s11535-012-0016-5
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.2478/s11535-012-0016-5